Nicole Dale

Pharma Writer, Pharmatica
  • South Africa
  • Joined 2026
3 Followers
7 Following

About

Nicole (BSc Molecular Medicine, Honours Medical Biochemistry) has many years of pharmaceutical experience, having worked for top CROs and biopharma companies for more than a decade.

Areas of Expertise

Published content

    • Oncology
    • FDA
    • Women's Health
    • Regulatory Approvals
    • Regulatory Pathways
    • Regulatory Strategy
    • Regulatory Submissions
    • Pharma Regulation
    • Global Regulatory Affairs
    • Clinical Trial Regulation
    • Regulatory & IP
    • Regulatory Consultation
    • Patient Registries
    • biomarkers
    • Translational Science and Biomarkers
    • Diagnostics
    • Oncology & Radiotherapeutics
    • Next-gen Modalities
    • Patient Care
    • Personalised Healthcare
    • Precision Medicine
    • Tech and Innovation
    • Commercial Strategy
    • Commercialisation & Medical Affairs
    • Pharma Policy
    • Market Access & Reimbursement
    • Post-market
    • Pricing and Market Access
    • Hospitals
    • Healthcare Providers
    • Medical Devices
    • Medtech
    • HealthTech
    • Clinical Trial Design
    • Clinical Outcomes
    • Adaptive Clinical Trials
    • clinical trials
    • Clinical Trial Strategy
    • Clinical Evidence
    • Clinical Data
    • Biostatistics

    Camizestrant Approval: First ctDNA-Guided Cancer Care

    • AI Drug Discovery
    • Cardiometabolic Diseases
    • Peptides and Obesity Treatments
    • AI in Clinical Trials
    • AI Pharma
    • AI & Machine Learning
    • AI and Automation
    • AI Drug Development
    • AI governance
    • AI vendor assessment
    • LLMs in Pharma
    • Machine Learning in Pharma
    • Biomedical R&D
    • Translational & Pre-clinical Research
    • Translational Science and Biomarkers
    • patient stratification
    • pharma R&D
    • Pharmaceutical R&D
    • biomarkers
    • Nonclinical Development
    • Preclinical Development
    • Computational Biology
    • Regulatory & IP
    • Regulatory Strategy
    • Pharma Regulation
    • Pharma Policy
    • Research Funding
    • Research Data
    • Research Informatics
    • Multiomics
    • Laboratory Quality
    • Drug Targets
    • Drug Design & Delivery
    • Drug Discovery
    • Investment and Market Analysis
    • Pharma Intelligence
    • Tech and Innovation
    • Data Integrity
    • Data Quality
    • The Discovery Loop
    • Target Identification
    • Target Validation
    • Enterprise Validation
    • Pharmacology
    • Generics
    • Genetics & Molecular Biology

    Novo Bets on AI Drug Discovery as GLP-1 Patents Near Expiry

    • Medtech
    • Diagnostics
    • Medical Imaging
    • Women's Health
    • Oncology
    • Oncology & Radiotherapeutics
    • Clinicians
    • HealthTech
    • Tech and Innovation
    • Biotech
    • AI & Advanced Healthcare
    • AI & Machine Learning
    • AI in Clinical Trials
    • AI vendor auditing
    • AI vendor assessment
    • Artificial Intelligence in Healthcare
    • Machine Learning in Pharma
    • LLMs in Pharma
    • Pharma Intelligence
    • Commercialisation & Medical Affairs
    • AI Pharma
    • Disease Screening
    • Preventative Care
    • Preventative Medicine
    • Cost-effectiveness
    • HTA and Reimbursement
    • Market Access & Reimbursement
    • Enterprise Validation
    • Pricing and Market Access
    • Personalised Healthcare
    • Hospitals
    • clinical trials
    • Clinical Data
    • Clinical Evidence
    • Clinical Outcomes
    • Regulatory Submissions
    • Regulatory Pathways
    • Regulatory Consultation
    • Regulatory Approvals
    • Regulatory & IP
    • Pharma Policy
    • Surgical Operations
    • Public Health
    • FDA
    • Precision Medicine

    AI Breast Cancer Screening Moves From Trials to Policy

    • Biopharmaceutical Manufacturing
    • Biologics
    • Continuous Manufacturing
    • Continuous Improvement
    • Pharmaceutical Compliance
    • Pharma Policy
    • Regulatory Pathways
    • Regulatory Consultation
    • Pharma Regulation
    • Contract Manufacturing (CDMO/CMO)
    • Decentralised Manufacturing
    • Good Manufacturing Practice
    • Manufacturing Technology
    • Pharmaceutical Manufacturing
    • Sterile Manufacturing
    • Demand Forecasting
    • Small Molecules
    • Next-gen Modalities
    • CMC
    • Trial Operations & CMC
    • Common Technical Document
    • Commercial Strategy
    • Global Regulatory Affairs
    • Quality Assurance & cGMP
    • Quality
    • Quality Assurance
    • Formulation
    • Data Quality
    • Data Integrity
    • Biotech
    • Pharma Supply Chains
    • Supply Network Strategy
    • Harmonisation Standards
    • Audit Findings
    • Site Inspection

    Continuous Manufacturing of Biologics Is Ready to Scale